about
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancerIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaEndocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsLung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell typesActivation of host wound responses in breast cancer microenvironmentIntegrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeStatistical modeling for selecting housekeeper genesUniversal Reference RNA as a standard for microarray experimentsPrediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell linesProgesterone receptor modulates ERα action in breast cancer.Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsMolecular portraits of human breast tumoursGenome Medicine in Cancer: What's in a Name?Repeated observation of breast tumor subtypes in independent gene expression data setsSystematic variation in gene expression patterns in human cancer cell linesComprehensive Molecular Portraits of Invasive Lobular Breast CancerBasal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeThe somatic genomic landscape of glioblastomaGenome remodelling in a basal-like breast cancer metastasis and xenograftA genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesSecreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathwayCorrection: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesDifferential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylationIntegrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinomaCharacterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsDiversity of gene expression in adenocarcinoma of the lungSupervised risk predictor of breast cancer based on intrinsic subtypesGenome-wide analysis of DNA copy-number changes using cDNA microarraysIdentification of genes periodically expressed in the human cell cycle and their expression in tumorsPhenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerResidual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresHuman epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data.Adjustment of systematic microarray data biases.Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer.The molecular portraits of breast tumors are conserved across microarray platforms.Gene expression patterns associated with p53 status in breast cancer.
P50
Q24291637-2BF8E133-F151-43D4-BF3A-9870D24EDDF4Q24612429-7089EB8A-F49B-496C-BE87-82F05CCD4DF0Q24621116-9ADB20C4-E61E-483D-946F-613BC332F9FEQ24632760-6207F671-6517-48B7-AA2E-0751BA2ED9C2Q24650013-11A9B517-FA43-440D-AB81-10869191E979Q24651548-BAAD60FD-35EA-48FA-8802-98B045D4FC92Q24684801-CB6023FB-F0A4-4DDA-8CF0-D807D6A202E9Q24797672-35BD8857-254B-4D7F-83BC-6CBD145FC141Q24805933-E7255779-DAC7-4563-A114-DB7BEB30D827Q24816504-CE71710B-C016-487D-9603-0F18344466E1Q27316268-CCC93566-9BCB-417B-8A3F-22B8EADF9A53Q27320285-B5370C03-4401-4789-80D1-2E5A43EB899DQ27860709-1914AFED-1A4A-4DFD-82BC-FB85B4C78A56Q28032461-795A949D-1FB9-4DD0-BDEA-3A4F1A10413DQ28085192-4E7F27D7-76A4-4772-8E77-AD5D6703ACAAQ28131820-4BF70A45-59B1-4F93-94F8-D3C22C67AC9AQ28145747-4F481444-DFAD-4DA6-A367-586C66CAD4B4Q28268284-A06A56EA-4655-4EB9-A285-0620599BBEA1Q28271274-DCA8A45F-297B-4FCF-A108-6AEF2A59133BQ28300185-30D99CBB-C926-4FFC-82F8-F13D1902AEC5Q28395637-D859D14D-8C60-4EEA-859A-0E54A02F6205Q28469084-CF59E943-E0EA-4689-90A8-66E2767788ECQ28505775-8D5CE6E4-D1C5-4539-8743-90720C726991Q28555233-60469E14-6AEC-432C-840A-70E4D8ACC7B4Q28730029-54B25975-B673-4424-87A5-0EF3C5937E47Q28730850-FDA340A0-BDF4-467E-B2B3-CBD3EECE2B55Q28751743-EC02A81F-66EF-4A85-A97F-BB4D45F6705DQ29616070-EBA5BD3E-B572-4B32-AA68-87E70C4C192FQ29617404-15649ECC-C7CB-499E-99EB-0209B6C08945Q29618942-4174C15F-EC91-4086-8C43-E801DA133314Q29619131-779D6724-6EBA-48C0-9846-3DFE37476942Q29619481-DF3E625D-22C9-464E-B06F-B56B818D68ADQ29620020-8D2F5614-33CA-430C-8997-A000523D7C6AQ30437453-C5A59B94-E1CF-4E21-AE4D-E974BBD0E400Q30496322-7B2CFA54-5332-4CF1-B4AD-624B869D788AQ30561080-3CEFBAD5-6909-4774-ACE1-6B4A0034670CQ30886734-6A9E0D39-FB70-434D-B48F-7D3356E5BC5FQ31123491-41F32D7C-93DF-41D8-8002-780271FCD5B1Q33241398-298FD114-11BE-4F3D-AD64-2B9D2EB3ACDBQ33265626-67E618FA-AE89-406B-A634-FF8F8895C2F5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charles M Perou
@es
Charles M Perou
@nl
Charles M Perou
@sl
Charles M. Perou
@en
Charles Perou
@fr
type
label
Charles M Perou
@es
Charles M Perou
@nl
Charles M Perou
@sl
Charles M. Perou
@en
Charles Perou
@fr
prefLabel
Charles M Perou
@es
Charles M Perou
@nl
Charles M Perou
@sl
Charles M. Perou
@en
Charles Perou
@fr
P1053
H-9934-2014
P106
P1153
7003834979
P21
P31
P3829
P496
0000-0001-9827-2247